SciELO - Scientific Electronic Library Online

 
vol.11 issue6The factors that influence the use of clinical protocols according to the opinion of the physical therapists of health center in the Autonomous Community of MurciaThe weeverfish sting author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Medifam

Print version ISSN 1131-5768

Abstract

BENITO RUIZ, P.  and  PROS SIMON, A.. Why an early treatment in rheumatoid arthritis?. Medifam [online]. 2001, vol.11, n.6, pp.53-61. ISSN 1131-5768.

Rheumatoid arthritis is an autoimmune disease characterized by chronic inflammation of diarthrodial joints, which may also cause involment of other organs. Today, most authors agree that nearly 80% of the patients will present with some degreee of disability after 10 years evolution. Prognosis of rheumatoid arthritis is uncertain, and lesions, that are produced in the first years of the disease, may progress despite clinical improvement, since pathogenesis of these lesions may differ from simple acute joint inflammation. Early diagnosis is therefore essential in order to start treatment before structural joint damage develops, since there is evidence that patients treated during the first year from the beginning of symptoms present better functional capacity outcome than those treated later.  Classic treatment for this disease had been based, until recently, on the traditional therapeutic pyramid which consisted in sequential introduction of drugs. Poor results of this strategy and awareness of the bad prognosis of the disease has demanded a reevaluation of its therapeutic approach. In this sense, introduction of remission induction agents early in the course of the disease seems appropiate, with the aim of reducing morbidity and functional disability.

Keywords : Rheumatoid arthritis; Treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License